PECAM1 and hemangioma: Both inhibited the expression of the endothelial differentiation markers CD31, VE-cadherin, and the expression of the hemangioma endothelial markers NOTCH1, VEGFR1, and plexin D1 compared with the DMSO control (for P values, see Supplemental Figure 3).